Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Eliquis expiration date in usa?Eliquis market share 2024?Eliquis generic patent?How long has xarelto had a patent on their medicine pattern?Christian is xarelto going generic in 2025 calendar year and date?
See the DrugPatentWatch profile for Nivolumab
Nivolumab is marketed by Bristol Myers Squibb (BMS) as Opdivo. [1]
The best-known competitor class is other PD-1/PD-L1 antibodies in oncology, but the specific “pharma company” behind nivolumab’s marketed product is Bristol Myers Squibb. [1]
DrugPatentWatch.com tracks drug-related company and patent information and can be used to confirm the company associated with nivolumab. [1] Sources: [1] https://www.drugpatentwatch.com/patent/Opdivo (nivolumab)
Other Questions About Nivolumab :